Secrets Of The S.O.S Repair Service

August 28, 1998

REHOVOT, Isreal, August 28, 1998--Some repair crews just do their job. Others go beyond the call of duty, leaving you better off than you were before the problem occurred. An emergency repair "service" that fixes DNA, the genetic material of cells, belongs to the second type.

Researchers at the Weizmann Institute of Science have now revealed the "trade secrets" of this molecular repair crew, demonstrating how a little genetic material patched into just the right place can save the DNA from a genetic disaster. And while averting a serious mutation, the repair squad leaves behind a surprising calling card: a "good" mutation, which can improve an organism's chance of survival.

DNA is regularly damaged by various factors in the environment, such as ultraviolet radiation. This damage is normally corrected with the help of special proteins known as repair enzymes. Sometimes, however, these enzymes fail to do their job.

Time to call the emergency repairmen. For more than 20 years, scientists have known that apart from the regular repair enzymes, DNA has a last- minute correction mechanism known as the S.O.S. repair. In a study reported in the August 28, 1998 issue of MOLECULAR CELL (Vol. 2, pp. 191-199), Prof. Zvi Livneh of the Weizmann Institute's Biological Chemistry Department, with graduate students Nina Reuven and Guy Tomer, reconstructed this mechanism in a test tube and revealed how the S.O.S. squad does its job.

The scientists found that when damaged genetic material is not repaired, the defective section of the DNA--usually consisting of one or two letters of the genetic code--is simply deleted during replication, and the rest of the DNA molecule shifts to fill in the gap. The result is a disastrous mutation that scrambles the genetic script.

This, in turn, leads to the production of defective proteins that can wreak havoc on cellular function. For example, such proteins can turn off the genes that suppress cancer, leading to the development of a tumor, or they can "kill" an essential protein, leading to cell death.

But when the S.O.S. repair does kick in, it replaces damaged DNA with random genetic material. This material acts as a spacer, keeping the DNA molecule in proper alignment. Similar o the way in which archaeologists fashion clay to fill the gaps between shards of an ancient pot, this "spacer" prevents the damaged genetic letters from being deleted and keeps the overall DNA structure intact.

The S.O.S. repair does not just prevent a genetic catastrophe, it actually provides an extra benefit. By introducing random genetic material into the spaces previously inhabited by defective DNA, the S.O.S. mechanism is creating a slightly mutated gene that is still functional and may work even better than the gene in its original form. In fact, such mild and beneficial mutations are the driving force behind evolution because they produce genetic diversity that serves as the basis of natural selection.

Understanding of this and other DNA repair mechanisms provides scientists with new insights into diseases such as cancer. Another potential application is in the area of treating bacterial infections. Because the S.O.S. stress response is one of the strategies used by bacteria to resist medications, understanding of this mechanism throws light on the alarming phenomenon of bacterial resistance to antibiotics.

Prof. Livneh holds the Maxwell Ellis Professorial Chair in Biomedical Research. This study was supported by the U.S.-Israel Binational Science Foundation, the Israel Ministry of Science and the Weizmann Institute's Leo and Julia Forchheimer Center for Molecular Genetics.

The Weizmann Institute of Science, in Rehovot, Israel, is one of the world's foremost enters of scientific research and graduate study. Its 2,500 scientists, students, technicians, and engineers pursue basic research in the quest for knowledge and the enhancement of the human condition. New ways of fighting disease and hunger, protecting the environment, and harnessing alternative sources of energy are high priorities.
Prof. Livneh may be reached in Israel, seven hours ahead of New York at:

011 972 8934 3203 lab
011 972 8946 1561 home

Weizmann Institute news releases are posted on the World Wide Web at and at

American Committee for the Weizmann Institute of Science

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to